| Literature DB >> 16265714 |
Dafna D Gladman1, Philip J Mease, Gerald Krueger, Désirée M F M van der Heidje, Christian Antoni, Philip S Helliwell, Arthur F Kavanaugh, Peter Nash, Christopher T Ritchlin, C Vibeke Strand, William Taylor.
Abstract
Recent advances in biologic therapies have provided hope for patients with psoriatic arthritis (PsA). However, studies have been hampered by the lack of acceptable and validated outcome measures. This article reviews outcome measures used in the assessment of both skin and joints in PsA, and provides a summary of the Psoriatic Arthritis Workshop during OMERACT 7. A set of domains to be included in the assessment of patients with PsA was derived, and a research agenda was developed.Entities:
Mesh：
Year: 2005 PMID： 16265714
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666